0 viewsjobseeker
Adam — CEO Biotechnology Cancer Research from South Africa

Adam

CEO Biotechnology Cancer Research

South Africa 6+ years
Open to offersNew to Platform
Languages
English
Video Introduction
No video introduction yet
The candidate has not added a video.
Contact information and social networks are private. Connect to unlock.
Hidden

Portfolios

1 items

About

Raashika A. is a South Africa-based Chief Executive Officer specializing in oncology biotechnology. With an academic foundation in Genetics and Developmental Biology, Raashika graduated Cum Laude from the University of the Witwatersrand. Leading Oncogenexe Biotech Pty Ltd, she steers groundbreaking therapeutic innovations for cancer treatment, advancing research with Next Generation Sequencing and clinical trials across Southern Africa. Previously serving as Chief Scientific Officer at Bionuclex Research Pty Ltd, Raashika was pivotal in designing early disease detection protocols, leveraging platforms like Illumina and Oxford Nanopore Technologies. She brings extensive expertise in regulatory strategy and trial management from roles at African Clinical Research Organization and BARC South Africa PTI, where she directed numerous oncology-focused studies and maintained rigorous compliance with global health authorities. Raashika's career is marked by her contributions to proteomics and bioinformatics, ensuring precision in antibody isolation and data privacy through quantum computing.

Experience

  • Chief Executive Officer / Executive Director

    Oncogenexe Biotech Pty Ltd · 2026 — Present
    Oversee oncology-focused clinical trials aimed at evaluating the safety and efficacy of various therapies, including antibody drug conjugates and targeted therapies for conditions like triple-negative breast cancer and pancreatic cancer.
  • Chief Scientific Officer

    Bionuclex Research Pty Ltd · 2024 — Present
    Engaged in protocol design for early disease detection within oncology, while managing phases of clinical trials and regulatory submissions. This includes implementing electronic data capturing systems and performing bioinformatic analyses using various technologies.
  • Regulatory Manager

    African Clinical Research Organization (ACRO) (HVTN) · 2021 — 2024
    Directed regulatory operations for clinical studies across multiple sites, ensuring adherence to protocols in South Africa and Sub-Saharan Africa. Responsibilities included maintaining clinical trial registries, managing protocol submissions, and facilitating site monitoring activities.
  • Clinical Trials Project Manager

    BARC South Africa PTI / CERBA PTY Ltd. · 2015 — 2021
    Managed setup and oversight for a multitude of pharmaceutical clinical trials, focusing on quality control, safety reviews, and budget analyses. Developed key documentation such as Investigator’s Brochures and clinical trial protocols while fostering collaboration among various departments.
  • Medical Scientist

    National Health Laboratory Service · 2007 — 2015
    Utilized advanced techniques for antibody isolation and performed drug sensitivity testing for tuberculosis using multiple assay methodologies. Conducted laboratory analyses and provided detailed reports to healthcare facilities, ensuring high standards of safety and accuracy.

Skills & Expertise

Education

  • MSc in Genetics and Developmental Biology
    University of the Witwatersrand · 2010 — 2010
  • BSc in Genetics and Developmental Biology
    University of the Witwatersrand · 2001 — 2003